Health
Researchers uncover potentially promising therapeutic combination for renal cell carcinoma – Medical Xpress
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney…
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide. Currently, the 5-year survival rate for patients with metastatic RCC is only about 12 percent. Current treatments include inhibitors of the VEGF and PD-1 pathways. However, resistance to therapy occurs in most patients and new combination treatments are still needed to enhance the efficacy of these current approaches.
Now,…
-
Noosa News19 hours agoWhat instrument did Japan’s heavy-metal PM play? Take the Brisbane Times Quiz
-
Business11 hours agoCould a small investor today match the historic returns of Warren Buffett?
-
Noosa News22 hours agoCompetition watchdog approves Elders’ $475m acquisition of agribusiness rival Delta
-
Noosa News22 hours agoFamily ‘quite nasty’ to woman who married step-uncle before his alleged murder, court hears